Results 51 to 60 of about 77,789 (337)
ChildrenDuctus arteriosus closure may be delayed in preterm infants, and prostaglandin, a vasodilator, can affect ductal patency. Furosemide can increase renal prostaglandin synthesis, so its net effect on patent ductus arteriosus (PDA) is uncertain. Our goal is
Chi-Mei Kuo +4 more
doaj +1 more source
Furosemide in pediatric intensive care: a retrospective cohort analysis
Frontiers in PediatricsIntroductionFurosemide is the most commonly used medication in pediatric intensive care. Growing data indicates improved hemodynamic stability and efficacy of furosemide infusions compared to intermittent injections, thereby suggesting furosemide ...
Melany Gaetani +17 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse +3 more
wiley +1 more source
Pakistan Journal of Analytical & Environmental Chemistry, 2021 The reported work discussed the simpler and sensitive strategy for the electrochemical determination of furosemide by employed tranexamic acid derived gold nanoparticles modified glassy carbon electrode (GCE).
Tasawar Ali Chandio +5 more
doaj +1 more source
Furosemide inhibits 11beta-hydroxysteroid dehydrogenase type 2.
, 1998 11Beta-hydroxsteroid dehydrogenase 2 (11beta-OHSD2) protects the nonselective renal mineralocorticoid receptor from the endogenous glucocorticoid cortisol. Thus, drugs inhibiting 11beta-OHSD2 might enhance urinary loss of potassium.
Fuster, D. +13 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga +20 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aim A prior non‐randomized study suggests that potassium supplementation may improve survival among furosemide initiators, and a randomized trial suggests that salt substitutes containing potassium might lower stroke risk. We conducted a retrospective cohort study using health‐care data to confirm or refute these associations among new users of ...
Thanh Phuong Pham Nguyen +8 more
wiley +1 more source
Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants
Jornal de Pediatria, 2018 Objective To evaluate the association between furosemide exposure and risk of bronchopulmonary dysplasia (BPD). Study design This retrospective cohort study included infants (2004‐2015) born at 23‐29 weeks gestational age and 501‐1249 g birth weight.
R. Greenberg +9 more
semanticscholar +1 more source
External validation of the BAN‐ADHF diuretic‐resistance score in the DAPA‐RESIST clinical trial
British Journal of Clinical Pharmacology, EarlyView.Diuretic resistance in worsening heart failure (HF) is associated with poorer outcomes and, although common, can be challenging to identify. The recently developed BAN‐ADHF score can potentially identify patients with worsening HF at risk of diuretic resistance.
Dominic M. Alfonso +10 more
wiley +1 more source